PAR 1.92% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Trading Halt, page-276

  1. 768 Posts.
    lightbulb Created with Sketch. 193
    And then a 2021 meta-analysis of 8 studies showing that the cartilage increases but has no benefit whatsoever.

    "The data from the included studies provide strong evidence to determine the effect of intra-articular sprifermin on joint structure in individuals with KOA and show no specific adverse effects. Nevertheless, intra-articular sprifermin did not likely have any positive effect on symptom alleviation."


    I'm sure patients will be lining up....
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.005(1.92%)
Mkt cap ! $89.19M
Open High Low Value Volume
26.5¢ 26.5¢ 25.5¢ $61.58K 238.1K

Buyers (Bids)

No. Vol. Price($)
2 62473 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 50000 1
View Market Depth
Last trade - 16.10pm 29/05/2024 (20 minute delay) ?
Last
26.0¢
  Change
-0.005 ( 1.07 %)
Open High Low Volume
26.5¢ 26.5¢ 25.5¢ 105880
Last updated 15.59pm 29/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.